☰ Sidebar
Voting period for this idea type has passed

SXSW 2022

Health Equality and the Science of Female Aging

1.1B women will reach menopause by 2025. With perimenopause begin as early as the late 30s—this generation will live more of their lives in menopause than not. Menopause has profound effects on lifespan and long-term health, yet remains poorly researched. With fertility market success and more leadership roles for women in midlife, attention and funding are finally directed to deepen understanding and mitigate health impacts. The work ranges from prolonging reproductive span to helping women extend their overall lifespan. Researchers and founders aim to bring more health equality to women over 40, a major cultural milestone with mindblowing science behind it. This panel will cover breakthrough research, technology and opportunities for go-to-market, and implications for women and society.

Share this idea


  1. Scientific solutions for ovarian aging is lacking. Promising new technology driven by CRISPR & organoid research now pave the path to intervention.
  2. The market is enormous for investors and entrepreneurs. Forbes noted that the menopause market alone is estimated to be worth $600 billion.
  3. Just 5% of women’s health startups—the “femtech” sector—funded in 2019 were focused on menopause. The opportunity to disrupt this market is profound.



Shannon Wilsey, Director, Sparkpr

Meta Information:

  • Event: SXSW
  • Format: Panel
  • Track: Health & MedTech
  • Track 2 Health & MedTech
  • Level: Advanced
Show me another idea

Add Comments

comments powered by Disqus

SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.